Looking at treatments possible in the next 5 years, I think that a treatment for
senile systemic amyloidosis, telomerase gene therapy, and thymus rejuvenation, in addition to the anti-aging therapies that are already available, would be able to allow some of the supercentenarians (110 +) to be able to make it past 122.